Curaleaf International's Subsidiary Teams Up With Germany's Zambon Spa To Provide Medical Cannabis Treatments

As Curaleaf International's subsidiary Adven GmbH seeks to advance its medical cannabis products in Germany, it has teamed up with an Italian pharmaceutical company, Zambon Spa, with whom it will provide medical cannabis treatments for patients, with an initial focus on neurological therapies.

Based in London, Curaleaf said Tuesday the first treatment will be launched in Germany in the months to come. The company's CEO, Antonio Costanzo said he is "delighted" to team up with Zambon. He called the deal "the first European pharmaceutical and medical cannabis partnership."

More Partnerships To Come

"We are looking forward to strengthening our collaboration and the creation of more such partnerships, where relevant pharmaceutical and medical cannabis expertise and excellence can be combined to advance the industry's understanding of medical cannabis for the rapidly growing European patient community," Costanzo continued.

Marco Castino, head of Region Europe in Zambon, stressed that medical cannabis as a supporting therapy is a "meaningful addition" to the company's portfolio in Europe.

"Our expertise in neurology and Curaleaf International's knowledge of the pharmaceutical active processes of cannabinoids provide ideal conditions to bring innovative treatment to patients,"  Castino said.

Adven GmbH launched its medical cannabis products in Germany - Europe's largest medical cannabis market - last month. The initial offering includes a high THC oil product. THC and CBD formulations in oil and flower formats are on the way.

Curaleaf International, previously known as EMMAC Life Sciences, was purchased by Curaleaf Holdings, Inc. CURA CURLF in April in a $310 million cash and stock deal.

The Wakefield, Massachusetts-based company created Curaleaf International Holdings Limited on the island of Guernsey to expand its European footprint.

Photo by Jhon David on Unsplash

Posted In: acquisitionAntonio CostanzoCuraleaf InternationalMarco CastinoZambonCannabisM&ANewsMarkets

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.